|
Volumn 100, Issue 1-3, 2008, Pages 97-107
|
Evolution of neuroleptic-induced extrapyramidal syndromes under long-term neuroleptic treatment
|
Author keywords
Akathisia; Evolution; Neuroleptics; Parkinson syndrome; Tardive dyskinesia
|
Indexed keywords
AMISULPRIDE;
ANTIPARKINSON AGENT;
ATYPICAL ANTIPSYCHOTIC AGENT;
CLOZAPINE;
NEUROLEPTIC AGENT;
OLANZAPINE;
QUETIAPINE;
RISPERIDONE;
SERTINDOLE;
ADULT;
AKATHISIA;
ARTICLE;
COMBINATION CHEMOTHERAPY;
COMPARATIVE STUDY;
CONTROLLED STUDY;
DOSE RESPONSE;
EXTRAPYRAMIDAL SYNDROME;
FEMALE;
HOSPITAL PATIENT;
HUMAN;
LONG TERM CARE;
MAJOR CLINICAL STUDY;
MALE;
MONOTHERAPY;
MOOD DISORDER;
MULTIVARIATE ANALYSIS;
ORGANIC BRAIN SYNDROME;
PARKINSONISM;
PREVALENCE;
PRIORITY JOURNAL;
SCHIZOAFFECTIVE PSYCHOSIS;
SCHIZOPHRENIA;
TARDIVE DYSKINESIA;
TREATMENT DURATION;
ADULT;
AKATHISIA, DRUG-INDUCED;
ANTIPSYCHOTIC AGENTS;
BASAL GANGLIA DISEASES;
CLOZAPINE;
DYSKINESIAS;
FEMALE;
FOLLOW-UP STUDIES;
HOSPITALIZATION;
HUMANS;
LONGITUDINAL STUDIES;
MALE;
MIDDLE AGED;
NEUROLOGIC EXAMINATION;
PARKINSONIAN DISORDERS;
PATIENT DROPOUTS;
PREVALENCE;
PSYCHOTIC DISORDERS;
SCHIZOPHRENIA;
SCHIZOPHRENIC PSYCHOLOGY;
|
EID: 39849090320
PISSN: 09209964
EISSN: None
Source Type: Journal
DOI: 10.1016/j.schres.2007.10.018 Document Type: Article |
Times cited : (27)
|
References (47)
|